Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A

As of June 30, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A carries a market capitalization of 3.96B, placing it among publicly traded companies globally. Its enterprise value stands at 4.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A's next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A has 134.67M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A recorded 1.58M in income tax expense.

As of the close on October 22, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A's stock has declined approximately 46.07% over the past 52 weeks. The 50-day moving average sits at 28.44, while the 200-day moving average is 34.34.

As of June 30, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A holds 355.19M in cash and equivalents against 409.04M in total debt, resulting in a net debt position of 47.69M. Total book value stands at 1.22B, with working capital of 438.47M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A paid dividends of 0.04 per share.